Subscribe To Our Free Newsletter |
Wockhardt’s once-a-day antibiotic drug ‘WCK 6777’ successfully concludes Phase I study
Also receives USFDA fast track designation
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!